Suraksha Diagnostic

275.25
-1.90
(-0.69%)
Market Cap
1,433.50 Cr
EPS
4.43
PE Ratio
45.16
Dividend Yield
0.00 %
Industry
0.00
52 Week High
449.00
52 Week Low
231.00
PB Ratio
7.19
Debt to Equity
0.56
Sector
0.00
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%

Company News

View All News
Caret
positive
Suraksha Diagnostic Acquires Majority Stake in Fetomat Wellness4 days ago
Suraksha Diagnostic has completed the acquisition of a 63% equity stake in Fetomat Wellness. This acquisition makes Fetomat Wellness a subsidiary of Suraksha Diagnostic.
positive
Suraksha Diagnostic Acquires Majority Stake in Fetomat Wellness5 days ago
Suraksha Diagnostic has completed the acquisition of a 63% equity stake in Fetomat Wellness. This acquisition makes Fetomat Wellness a subsidiary of Suraksha Diagnostic.
Growth Rate
Revenue Growth
14.77 %
Net Income Growth
278.69 %
Cash Flow Change
37.14 %
ROE
231.03 %
ROCE
137.02 %
EBITDA Margin (Avg.)
-

Quarterly Financial Results

Quarterly Financials
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
53
61
53
56
62
68
60
Expenses
37
39
37
37
40
44
41
EBITDA
16
21
16
20
22
25
19
Operating Profit %
28 %
35 %
30 %
34 %
34 %
35 %
31 %
Depreciation
8
8
8
8
9
9
9
Interest
2
3
2
2
2
2
2
Profit Before Tax
5
11
6
9
11
14
8
Tax
1
3
2
3
3
4
2
Net Profit
4
8
5
6
8
10
6
EPS in ₹
1.17
2.44
0.87
1.89
1.49
1.94
1.18

Balance Sheet

Balance Sheet
2023
2024
Total Assets
281
300
Fixed Assets
195
212
Current Assets
68
72
Capital Work in Progress
2
1
Investments
0
0
Other Assets
84
87
Total Liabilities
281
300
Current Liabilities
38
39
Non Current Liabilities
87
82
Total Equity
156
179
Reserve & Surplus
147
171
Share Capital
9
9

Cash Flow

Cash Flow
2020
2021
2022
2023
2024
Net Cash Flow
1
-1
-0
-1
0
Investing Activities
-20
-28
-44
-21
-35
Operating Activities
31
24
42
44
61
Financing Activities
-10
3
1
-24
-25

Share Holding

% Holding
Jul 2024
Nov 2024
Dec 2024
Mar 2025
Promoter
72.41 %
61.06 %
48.78 %
48.78 %
FIIs
0.00 %
0.00 %
15.39 %
14.46 %
DIIs
0.00 %
0.00 %
20.44 %
22.05 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
0.00 %
14.08 %
13.52 %
Others
27.59 %
38.94 %
1.31 %
1.19 %
No of Share Holders
10
10
10
87,275

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Corporate Action

Announcements

Announcement under Regulation 30 (LODR)-Updates on Acquisition5 days ago
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 20186 days ago
Announcement under Regulation 30 (LODR)-Updates on Acquisition7 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 28, 2025
Announcement under Regulation 30 (LODR)-AcquisitionMar 27, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Held On 27 March 2025Mar 27, 2025
Closure of Trading WindowMar 24, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMar 07, 2025
Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)Feb 17, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 14, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportFeb 10, 2025
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotFeb 10, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 10, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 10, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementFeb 08, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 08, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 08, 2025
Integrated Filing (Financial)Feb 08, 2025
Unaudited Financial Results (Standalone And Consolidated) Of The Company For Quarter And Nine Months Ended 31 December 2024 Feb 08, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On 08 February 2025Feb 08, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 05, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Feb 03, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 03, 2025
Board Meeting Intimation for Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended 31 December 2024Feb 03, 2025
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosures Requirements) Regulations 2015- Incorporation Of The Subsidiary Of The CompanyJan 22, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementJan 16, 2025
Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)Jan 16, 2025
Intimation For Change Of Corporate Identification Number (CIN) And Listing Status Of The CompanyJan 08, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 07, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 07, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 07, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotJan 06, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptDec 30, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeDec 23, 2024
Board Meeting Intimation for Board Meeting Intimation Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015Dec 14, 2024
Resignation Of Mr. Bhaskar Ghoshal, Chief Operating Officer (Senior Management) Of The Company.Dec 12, 2024
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011Dec 09, 2024
Disclosure Under Regulation 30(5) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations)Dec 09, 2024
Closure of Trading WindowDec 06, 2024
Listing of Equity Shares of Suraksha Diagnostic LtdDec 06, 2024

Technical Indicators

RSI(14)
Neutral
47.13
ATR(14)
Less Volatile
14.32
STOCH(9,6)
Neutral
60.19
STOCH RSI(14)
Neutral
74.51
MACD(12,26)
Bullish
1.76
ADX(14)
Strong Trend
28.44
UO(9)
Bearish
51.10
ROC(12)
Downtrend And Accelerating
-3.52
WillR(14)
Neutral
-52.86